Autopsy report · NCT03694483

Prostasomes as Diagnostic Tool for Prostate Cancer Detection

“Staffing changes, pending funding renewal”

The sponsor’s own words in the registry.

Life of this trial

• Suspended: paused, and may or may not restart.
• 600 participants planned (an estimate, not an actual count).

Vital statistics

Status

Suspended

Sponsor

Hackensack Meridian Health

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

Genetic analysis for the detection of prostasomes

Participants

600 (planned, not actual)

Sites

1

Countries

United States

Trials that died the same way

• Image Biomarkers for Progression of AMD
  “Funding for staff no longer available” (68% match in meaning)
• Sex Differences in Neurobehavioral Response to THC
  “Funding status change.” (65% match in meaning)
• Optimizing Ovulation Induction in the Poor Responder
  “Change in staffing” (65% match in meaning)
• Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks
  “Funding changes.” (64% match in meaning)
• Muscle Function After Childbirth
  “Personnel changes pending” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.